Haemonetics (HAE) Tops Q3 EPS by 2c; updates guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $74.85 -0.2%
Revenue Growth %: +2.3%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
CRMT, FOMI, FLES, More
Revenue Growth %: +2.3%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $1.19, $0.02 better than the analyst estimate of $1.17. Revenue for the quarter came in at $349 million versus the consensus estimate of $352.98 million.
GUIDANCE:
Haemonetics sees FY2025 EPS of $4.50-$4.70, versus the consensus of $4.59.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Cleveland-Cliffs wins $400M Defense steel contract
- Activist group calls for Genesco director to resign over credential claims
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
